Randomized double-blind, comparative study of abiraterone acetate (AA) plus low-dose prednisone (P) plus androgen deprivation therapy (ADT) versus ADT alone in newly diagnosed, high-risk, metastatic hormone-naive prostate cancer (mHNPC).
Karim Fizazi
Consultant or Advisory Role - Janssen
Honoraria - Janssen
Julie S. Larsen
Employment or Leadership Position - Janssen Research & Development
Shannon Matheny
Employment or Leadership Position - Janssen
Stock Ownership - Johnson & Johnson
Arturo Molina
Employment or Leadership Position - Johnson & Johnson
Stock Ownership - Johnson & Johnson
Jinhui Li
Employment or Leadership Position - Janssen Research & Development
Mary Beth Todd
Employment or Leadership Position - Janssen
Stock Ownership - Johnson & Johnson
Margaret K. Yu
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Janssen Research & Development
Thian San Kheoh
Employment or Leadership Position - Janssen
Stock Ownership - Johnson & Johnson
Namphuong Tran
Employment or Leadership Position - Janssen
Stock Ownership - Johnson & Johnson